carbostyril has been researched along with Carcinoma, Small Cell Lung in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aboubakar Nana, F; Detry, B; Dupasquier, S; Feron, O; Ladjemi, MZ; Lecocq, M; Massion, PP; Ocak, S; Pilette, C; Sibille, Y | 1 |
Inoue, H; Kato, T; Matsuo, Y; Miyamoto, T; Nakamura, Y; Park, JH; Salgia, R; Zewde, M | 1 |
2 other study(ies) available for carbostyril and Carcinoma, Small Cell Lung
Article | Year |
---|---|
Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer.
Topics: Cell Adhesion; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Focal Adhesion Kinase 1; Humans; Lung Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Quinolones; RNA, Small Interfering; Small Cell Lung Carcinoma; Sulfones | 2019 |
TOPK (T-LAK cell-originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer.
Topics: Cell Proliferation; Forkhead Box Protein M1; Humans; Lung Neoplasms; Mitogen-Activated Protein Kinase Kinases; Neoplastic Stem Cells; Quinolones; RNA Interference; RNA, Small Interfering; Small Cell Lung Carcinoma; Spheroids, Cellular; Thiophenes; Thy-1 Antigens; Tumor Cells, Cultured | 2017 |